All News

Negative pressure wound therapy has been a staple in hospital settings, but clinical data suggests its benefits are more significant than previously thought.

Lebrikizumab enables 8‑week maintenance dosing for severe eczema, reducing injections to 6 yearly while maintaining strong skin‑clearance results.

AI reshapes everyday tasks in the community pharmacy from refill automation to documentation.

Reports state that everyone from “shadowy online vendors” to physicians and nurses is illegally promoting the drug before it receives proper FDA approval.

Phase 3 data show a once-weekly HIV pill maintains viral suppression like daily therapy, hinting at simpler long-acting care.

This episode explores the true price of commitment to a dream or vision, explaining how anything less than full dedication can lead to failure and why small wins are essential for perseverance.

The decision represents the first new sunscreen ingredient permitted in the United States since the late 1990s.

Alongside malnutrition instances and measles cases, researchers review pneumonia disease burden and immune vulnerability across high-risk pediatric groups.

Based on data from the ADA’s 2026 Scientific Sessions, glucagon-like peptide-1s are continuing to revolutionize the cardiometabolic disease landscape.

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

Medicare’s $35 insulin cap cuts cost swings, boosts adherence for high-burden patients, and highlights pharmacists’ role in preventing rationing.

As pneumococcal disease continues to rise since the COVID-19 pandemic, researchers looked at the need to escalate the management of serotype surveillance and vaccine coverage.

BA.3.2 variant spreads globally, testing vaccine matches as the FDA backs XFG immunizations.

The Age-Friendly Pharmacy certification and the 4Ms reshape senior care, teamwork, and deprescribing by putting the patient in the center of care.

The AI-led initiative was designed to conduct audits and ensure appropriate distribution of health care funds for federal programs.

Alabama bans research-grade peptides for patients amid FDA reviewing 12 peptides for compounding use.

New 9-year data shows some high-risk prediabetes patients progress to type 2 diabetes despite 8% weight loss.

In an evolving health care landscape bringing all providers into a primary care team, diabetes is no different and the pharmacist community can offer so much for patients.

Federal court blocks abrupt childhood vaccine schedule changes, raising insurance and liability uncertainty as pharmacies navigate shifting guidance and growing parent hesitancy.

Recent research data assessed the potential use of GLP-1s for reducing the progression of total knee arthroplasty.

Episode 10 addresses recent changes to the AACE diabetes guidelines and what pharmacists need to do to stay informed.

In part 2 of our interview with Sandra Leal, PharmD, MPH, she explored the ADA Standards of Care and how pharmacists are positioned to assist in interoperable diabetes management.

The executive order calls to realign core childhood vaccine recommendations with scientific evidence and best practices of peer, developed nations.

Pharmacists can prevent heat illness through medication reviews and safety plans.

Exploring both the PCV20 and PCV21 pneumococcal vaccines, researchers compare the differences in immune effects between patients at 50 and 65 years old.

Bepirovirsen suggests that a finite 24-week treatment course can achieve a functional cure defined as sustained undetectable hepatitis B surface antigen.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Pharmacists flag risky medications, safeguard cold-chain supplies, and counsel with the HEAT checklist.